Petrus Trust Company LTA Invests $219,000 in Astera Labs, Inc. $ALAB

Key Points

• Petrus Trust Company LTA has made a new investment of $219,000 in Astera Labs, acquiring 3,665 shares during the 1st quarter.
• Astera Labs' stock received multiple price target increases from analysts, with Jefferies raising theirs from $95 to $130, reflecting confidence in the company's performance.
• Insiders at Astera Labs have sold a significant amount of stock recently, with CFO Michael Truett Tate selling shares valued at $17.14 million, indicating a 16.16% decrease in his ownership.

Petrus Trust Company LTA acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 3,665 shares of the company's stock, valued at approximately $219,000.

Several other hedge funds have also modified their holdings of ALAB. Dimensional Fund Advisors LP raised its holdings in shares of Astera Labs by 4.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 18,250 shares of the company's stock worth $2,417,000 after acquiring an additional 768 shares in the last quarter. Cetera Investment Advisers purchased a new stake in shares of Astera Labs during the 4th quarter worth approximately $460,000. Cresset Asset Management LLC purchased a new stake in shares of Astera Labs during the 4th quarter worth approximately $216,000. Deutsche Bank AG raised its holdings in shares of Astera Labs by 33.0% during the 4th quarter. Deutsche Bank AG now owns 7,695 shares of the company's stock worth $1,019,000 after acquiring an additional 1,909 shares in the last quarter. Finally, Ethic Inc. purchased a new stake in shares of Astera Labs during the 4th quarter worth approximately $656,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction on Thursday, August 28th. The stock was sold at an average price of $188.70, for a total value of $1,887,000.00. Following the sale, the general counsel owned 161,573 shares in the company, valued at $30,488,825.10. This trade represents a 5.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 91,441 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the sale, the chief executive officer owned 2,170,877 shares in the company, valued at approximately $398,377,638.27. The trade was a 4.04% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,832,489 shares of company stock valued at $264,172,396. Insiders own 12.50% of the company's stock.

Astera Labs Stock Performance

ALAB stock traded down $3.40 during midday trading on Friday, reaching $229.50. The company's stock had a trading volume of 3,692,811 shares, compared to its average volume of 4,689,180. The stock has a fifty day simple moving average of $155.12 and a two-hundred day simple moving average of $103.82. Astera Labs, Inc. has a 1 year low of $41.47 and a 1 year high of $237.82. The firm has a market capitalization of $38.15 billion, a price-to-earnings ratio of 409.82, a PEG ratio of 5.91 and a beta of 1.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same quarter last year, the firm posted $0.13 earnings per share. The business's revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ALAB has been the topic of several recent research reports. Morgan Stanley upped their price objective on Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a report on Friday, August 29th. Wall Street Zen upgraded Astera Labs from a "hold" rating to a "buy" rating in a report on Saturday, August 16th. Stifel Nicolaus set a $145.00 price target on Astera Labs and gave the company a "buy" rating in a report on Monday, August 4th. Deutsche Bank Aktiengesellschaft increased their price target on Astera Labs from $160.00 to $200.00 and gave the company a "buy" rating in a report on Tuesday, September 2nd. Finally, Barclays restated an "overweight" rating and set a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a report on Thursday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Astera Labs has a consensus rating of "Moderate Buy" and a consensus target price of $142.00.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.